Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|February 25, 2016
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisXuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysisXuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2009
Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriersMieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.BMC Cancer|October 4, 2012
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSepideh Saadatmand, Emiel J T Rutgers, Rob A E M Tollenaar, et al.The New England Journal of Medicine|July 30, 2004
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.Breast Cancer Research and Treatment|October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerM Kriege, C T M Brekelmans, H Peterse, et al.Breast Cancer Research and Treatment|June 23, 2006
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancerMieke Kriege, Cecile T M Brekelmans, Inge Marie Obdeijn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening StudyAdriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2012
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combinedEveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, et al.The Lancet. Oncology|June 22, 2019
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, et al.Pageof 6